MPS Management Change
MPS Ltd appointed Mr. Atul Vohra as an Additional Director, effective July 6, 2026, pending shareholder approval. His profile highlights global leadership experience across multiple sectors.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
47 announcements with these filters
MPS Ltd appointed Mr. Atul Vohra as an Additional Director, effective July 6, 2026, pending shareholder approval. His profile highlights global leadership experience across multiple sectors.
Mr. Raman Sapra resigned as Company Secretary and Compliance Officer of MPS Limited, effective August 2026. The departure for personal reasons triggers a management transition.
MPS Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no new deviations noted.
MPS Limited reports FY26 as its most profitable year, driven by AI-led knowledge solutions and the acquisition of Unbound Medicine.
MPS closed FY26 with record profitability, driven by its transformation into an AI-first knowledge solutions provider and the successful integration of Unbound Medicine.
MPS Limited's board decided not to recommend a final dividend for FY2025-26. Capital is being retained to support growth following the Unbound Medicine acquisition.
MPS Limited reported record FY26 EPS of ₹102.11 (+16.3% YoY) with consolidated EBITDA of ₹236 Cr (30.7% margin), driven by an AI-first strategy and the Unbound Medicine acquisition.
MPS Ltd reported revenue from operations of ₹205.2 Cr (+12.7% YoY) and net profit of ₹47 Cr (-0.2% YoY) for Q4 FY26.
MPS Limited announced the voluntary de-registration of its Australian step-down subsidiary, App-eLearn Pty Ltd. The closure has no material impact on the company's consolidated financials.
MPS Limited scheduled a board meeting on 15 May 2026 to consider Q4 FY26 financial results and dividend recommendations. The meeting signals upcoming performance disclosures for shareholders.
Mr. Sreenivas Trichy Venkatraman has resigned as Chief Operating Officer (Senior Management Personnel) of MPS Limited due to personal reasons. His resignation is effective from the close of business hours on August 03, 2026. The company has accepted the resignation and taken it on record.
Mr. Sreenivas Trichy Venkatraman has resigned from his position as Chief Operating Officer of MPS Limited. His resignation was received on May 5, 2026, and will be effective from August 3, 2026.
MPS Limited announced the resignation of Chief Operating Officer Mr. Sreenivas Trichy Venkatraman, effective August 03, 2026. The company has accepted his resignation, and he will continue in his role until the stated date. This transition marks a change in senior management for the company.
MPS Limited has approved the 5th grant of 79,009 employee stock options with a total value of ₹13.1 Crore. Options will vest equally over four years and have an exercise price of ₹1,657.70 per share. This initiative aims to align employee interests with shareholder value creation.
MPS Limited received an Income Tax Assessment Order and Demand Notice for ₹21.78 Crore for AY 2023-24. The company believes the demand is inflated due to an incorrect tax rate and is filing for rectification and appeal. No material impact on business operations is expected.
Nishith Arora Family Trust and NAFT-2 confirmed complete compliance with SEBI exemption orders for the financial year ended March 31, 2026. The trusts facilitate internal promoter group succession planning for shares in ADI BPO Services and ADI Media, which control MPS Limited. Independent auditors verified that all conditions of the Takeover Regulations exemptions were met.
MPS Limited submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The certificate from RTA Cameo Corporate Services confirms the processing and listing of dematerialized securities. This is a routine quarterly regulatory filing with no material business impact.